Pulse Biosciences Inc

NASDAQ:PLSE   3:59:53 PM EDT
1.82
+0.03 (+1.68%)
Earnings Announcements

Pulse Biosciences Reports First Quarter 2022 Financial Results

Published: 05/11/2022 20:53 GMT
Pulse Biosciences Inc (PLSE) - Pulse Biosciences Reports First Quarter 2022 Financial Results.
Pulse Biosciences Inc - Cash, Cash Equivalents and Investments Totaled $12.7 Million As of March 31, 2022.
Pulse Biosciences Inc - Qtrly Basic and Diluted Net Loss per Share $0.58.
Revenue is expected to be $0.44 Million
Adjusted EPS is expected to be -$0.40

Next Quarter Revenue Guidance is expected to be $0.46 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.